Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidiuretic effectiveness of imidafenacin in overactive bladder patients with nocturia
jRCT1091220405Completed
- Sponsor
- Kindai University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of imidafenacin in overactive bladder (OAB) and nocturia, sponsored by Kindai University. Primary endpoint: urine osmotic pressure. Started Jan 2019; status: completed.
02
Drugs
imidafenacin
03
Conditions
overactive bladder (OAB)nocturia
Beyond the preview
Go deeper on jRCT1091220405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220405.